Cadila launches generic versions of type 2 diabetes drug Sitagliptin in India - ETHealthWorld

Sitagliptin has a strong clinical profile and the potential to revolutionise the treatment of type 2 diabetes for millions of people who do not achieve the targeted blood sugar level with currently available anti-diabetic medications.

Ahmedabad: Cadila Pharmaceuticals has launched the generic versions of Sitagliptin in India under the brand names Jankey & Sitenali to address type 2 diabetes.Sitagliptin is a drug from the class… [+1645 chars]

full article...